• This record comes from PubMed

Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity

. 2022 Jun 09 ; 74 (6) : 887-895.

Language English Country Great Britain, England Media print

Document type Journal Article

Grant support
CZ.02.1.01/0.0/0.0/16_019/0000841 EFSA-CDN project
SVV 260 549 ERDF
Charles University

OBJECTIVES: Both pyridine and pyrano derivatives have been previously shown to possess biologically relevant activity. In this study, we report the incorporation of these two scaffolds into one molecule. METHODS: The designed 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines were synthesized by the acylation of enamine under Stork conditions followed by condensation of formed β-diketones with 2-cyanoacetamide. The structures of these compounds were confirmed by using a wide spectrum of physico-chemical methods. Their antiplatelet, anticoagulant and vasodilatory activity together with toxicity were evaluated. KEY FINDINGS: A series of 6-oxopyrano[3,4-c]pyridines 3a-j was obtained. Four of these compounds were reported for the first time. None of the tested compounds demonstrated anticoagulant effect but 8-methyl derivative (3a) was a potent antiplatelet compound with IC50 numerically twice as low as the clinically used acetylsalicylic acid. A series of further mechanistic tests showed that 3a interferes with calcium signaling. The compound is also not toxic and in addition possesses vasodilatory activity as well. CONCLUSIONS: Compound 3a is a promising inhibitor of platelet aggregation, whose mechanism of action should be studied in detail.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Can Isoquinoline Alkaloids Affect Platelet Aggregation in Whole Human Blood?

. 2022 Jul 15 ; 14 (7) : . [epub] 20220715

Comparison of Antiplatelet Effects of Phenol Derivatives in Humans

. 2022 Jan 12 ; 12 (1) : . [epub] 20220112

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...